HMGCS2 and metabolic dysfunction-associated steatotic liver disease: They found that the high-fat-diet feeding of HMGCS2-eliminated mice resulted in increased hepatic injury and inflammation and, therefore, suggested that ketogenesis may modulate nonalcoholic fatty liver disease [28].